Moraxella catarrhalis: A mini review

Journal of Pediatric Infectious Diseases

Volumn 4, Issue 3, 2009, Pages 211-220

  Hays, John P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Beta lactamase; Colonization; Immune response; Moraxella catarrhalis

Indexed keywords

AMOXICILLIN; AMPICILLIN; BACTERIAL VACCINE; BETA LACTAMASE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CELL SURFACE PROTEIN; CIPROFLOXACIN; COTRIFAMOLE; DOXYCYCLINE FOSFATEX; ERYTHROMYCIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MACROLIDE; PENICILLIN G; QUINOLONE DERIVATIVE; TETRACYCLINE; UBIQUITIOUS CELL SURFACE PROTEIN A1; UBIQUITIOUS CELL SURFACE PROTEIN A1 VACCINE; UBIQUITIOUS CELL SURFACE PROTEIN A2H; UBIQUITIOUS CELL SURFACE PROTEIN A2H VACCINE; UNCLASSIFIED DRUG;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; ANTIBODY TITER; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CYTOKINE RELEASE; GENE INTERACTION; GENOTYPE; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNE RESPONSE; MORAXELLA CATARRHALIS; NASOPHARYNX; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION;

EID: 68349154409     PISSN: 13057707     EISSN: None     Source Type: Journal    
DOI: 10.3233/JPI-2009-0167     Document Type: Review

References (142)

1. P. Frosch and W. Kolle, Die mikrokokken, in: Die Mikroorganism, (3rd ed.), C. Flugge, ed., Leipzig, Germany: Verlag von Vogel, 1896, pp. 154-155 (in German).
2. F.R. Conceicao, F. Paolicchi, A.L. Cobo and C. Gil-Turnes, Antigenic relationships of Moraxella bovis isolates recovered from outbreaks of infectious bovine keratoconjunctivitis in Argentina, Brazil, and Uruguay between 1983 and 2000, Can J Vet Res 67 (2003), 315-318.
3. G. Jannes, M. Vaneechoutte, M. Lannoo et al., Polyphasic taxonomy leading to the proposal of Moraxella canis sp. nov. for Moraxella catarrhalis-like strains, Int J Syst Bacteriol 43 (1993), 438-449.
4. N. Nagano, J. Sato, C. Cordevant, Y. Nagano, F. Taguchi and M. Inoue, Presumed endocarditis caused by Bro beta-lactamase-producing Moraxella lacunata in an infant with Fallot's tetrad, J Clin Microbiol 41 (2003), 5310-5312.
5. X.Y. Han and J.J. Tarrand, Moraxella osloensis blood and catheter infections during anticancer chemotherapy: Clinical and microbiologic studies of 10 cases, Am J Clin Pathol 121 (2004), 581-587.
6. J.M. Davis, M.J. Whipp, C. Ashhurst-Smith, J.C. DeBoer and M.M. Peel, Mucoid nitrate-negative Moraxella nonliquefaciens from three patients with chronic lung disease, J Clin Microbiol 42 (2004), 3888-3890.
7. D.W. Johnson, G. Lum, G. Nimmo and C.M. Hawley, Moraxella nonliquefaciens septic arthritis in a patient undergoing hemodialysis, Clin Infect Dis 21 (1995), 1039-1040.
8. J.M. Sudar, M.J. Alleman, G.J. Jonkers, R. de Groot and C. Jongejan, Acute thyroiditis caused by Moraxella nonliquefaciens, Neth J Med 45 (1994), 170-173.
9. H. Laukeland, K. Bergh and L. Bevanger, Posttrabeculectomy endophthalmitis caused by Moraxella nonliquefaciens, J Clin Microbiol 40 (2002), 2668-2770.
10. T. De Baere, A. Muylaert, E. Everaert et al., Bacteremia due to Moraxella atlantae in a cancer patient, J Clin Microbiol 40 (2002), 2693-2695.
11. J.E. Gordon, The gram-negative cocci in "colds" and influenza, J Infect Dis 29 (1921), 462-494.
12. J.P. Hays, The genus Moraxella, in: The Prokaryotes, (3rd ed.), M. Dworkin, S. Falkow, E. Rosenberg, K.H. Schleifer and E. Stackebrandt, eds, New York: Springer, 2007, pp. 958-987.
13. C.M. Verduin, C. Hol, A. Fleer, H. van Dijk and A. van Belkum, Moraxella catarrhalis: From emerging to established pathogen, Clin Microbiol Rev 15 (2002), 125-144.
14. H.J. Bootsma, H.G. van der Heide, S. van de Pas, L.M. Schouls and F.R. Mooi, Analysis of Moraxella catarrhalis by DNAtyping: Evidence for a distinct subpopulation associated with virulence traits, J Infect Dis 181 (2000), 1376-1387.
15. T. Wirth, G. Morelli, B. Kusecek et al., The rise and spread of a new pathogen: Seroresistant Moraxella catarrhalis, Genome Res 17 (2007), 1647-1656.
16. H. Faden, Y. Harabuchi and J.J. Hong, Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media, J Infect Dis 169 (1994), 1312-1317.
17. E. Varon, C. Levy, F. De La Rocque et al., Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections, Clin Infect Dis 31 (2000), 477-481.
18. J.A. Garcia-Rodriguez and M.J. Fresnadillo Martinez, Dynamics of nasopharyngeal colonization by potential respiratory pathogens, J Antimicrob Chemother 50(Suppl S2) (2002), 59-73.
19. B. Leaños-Miranda, M.G. Miranda-Novales, F. Solórzano-Santos, L. Ortiz-Ocampo and H. Guiscafré-Gallardo, Prevalence of Moraxella catarrhalis colonization in asymptomatic carriers under 6 years of age, Salud Publica Mex 43 (2001), 27-31 (in Spanish).
20. T. Ejlertsen, E. Thisted, F. Ebbesen, B. Olesen and J. Renneberg, Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections, J Infect 29 (1994), 23-31.
21. T. Ejlertsen, Pharyngeal carriage of Moraxella (Branhamella) catarrhalis in healthy adults, Eur J Clin Microbiol Infect Dis 10 (1991), 89.
22. H. Bisgaard, M.N. Hermansen, F. Buchvald et al., Childhood asthma after bacterial colonization of the airway in neonates, N Engl J Med 357 (2007), 1487-1495.
23. P.G. Gibson J.E. Stuart, J. Wlodarczyk, L.G. Olson and M.J. Hensley, Nasal inflammation and chronic ear disease in Australian aboriginal children, J Paediatr Child Health 32 (1996), 143-147.
24. A.J. Leach, J.B. Boswell, V. Asche, T.G. Nienhuys and J.D. Mathews, Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants, Pediatr Infect Dis J 13 (1994), 983-989.
25. H. Smith-Vaughan, R. Byun, M. Nadkarni et al., Measuring nasal bacterial load and its association with otitis media, BMC Ear Nose Throat Disord 6 (2006), 10.
26. R.K. Gunnarsson, S.E. Holm and M. Soderstrom, The prevalence of potential pathogenic bacteria in nasopharyngeal samples from healthy children and adults, Scand J Prim Health Care 16 (1998), 13-17.
27. K. Hatakka, K. Blomgren, S. Pohjavuori et al., Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study, Clin Nutr 26 (2007), 314-321.
28. J.P. Hays, C. van der Schee, A. Loogman et al., Total genome polymorphism and low frequency of intra-genomic variation in the UspA1 and UspA2 genes of Moraxella catarrhalis in otitis prone and non-prone children up to 2 years of age. Consequences for vaccine design? Vaccine 21 (2003), 1118-1124.
29. N. Heiniger, V. Spaniol, R. Troller, M. Vischer and C. Aebi, A reservoir of Moraxella catarrhalis in human pharyngeal lymphoid tissue, J Infect Dis 196 (2007), 1080-1087.
30. M.E. Pichichero and J.R. Casey, Otitis media, Expert Opin Pharmacother 3 (2002), 1073-1090.
31. T.F. Murphy, A.L. Brauer, B.J. Grant and S. Sethi, Moraxella catarrhalis in chronic obstructive pulmonary disease: Burden of disease and immune response, Am J Respir Crit Care Med 172 (2005), 195-199.
32. V.K. Hart, The bacteriology of acute ears, Laryngoscope 37 (1927), 56-61.
33. H. Gunasekera, L. Haysom, P. Morris and J. Craig, The global burden of childhood otitis media and hearing impairment: A systematic review, Pediatrics 121 (2008), S107.
34. D. Turner, E. Leibovitz, A. Aran et al., Acute otitis media in infants younger than two months of age: Microbiology, clinical presentation and therapeutic approach, Pediatr Infect Dis J 21 (2002), 669-674.
35. R. Karalus and A. Campagnari, Moraxella catarrhalis: A review of an important human mucosal pathogen, Microbes Infect 2 (2002), 547-559.
36. H. Faden, The microbiologic and immunologic basis for recurrent otitis media in children, Eur J Pediatr 160 (2001), 407-413.
37. G.M. Wood, B.C. Johnson and J.G. McCormack, Moraxella catarrhalis: pathogenic significance in respiratory tract infections treated by community practitioners, Clin Infect Dis 22 (1996), 632-636.
38. B. Winther, F.G. Hayden, E. Arruda, R. Dutkowski, P. Ward and J.O. Hendley, Viral respiratory infection in schoolchildren: Effects on middle ear pressure, Pediatrics 109 (2002), 826-832.
39. A. Broides, E. Leibovitz, R. Dagan et al., Cytology of middle ear fluid during acute otitis media, Pediatr Infect Dis J 21 (2002), 57-61.
40. T. Heikkinen, F. Ghaffar, A.O. Okorodudu and T. Chonmaitree, Serum interleukin-6 in bacterial and nonbacterial acute otitis media, Pediatrics 102 (1998), 296-299.
41. C.D. Bluestone, Otitis media and sinusitis in children. Role of Branhamella catarrhalis, Drugs 31(Suppl 3) (1986), 132-141.
42. S. Bodkin and D. Warde, Moraxella catarrhalis - an unusual pathogen in bacterial tracheitis, Ir Med J 86 (1993), 208-209.
43. Y. Kobayashi, Bacteremic Moraxella catarrhalis pneumonia, J Infect Chemother 6 (2000), 68.
44. R. Manfredi, A. Nanetti, R. Valentini and F. Chiodo, Moraxella catarrhalis pneumonia during HIV disease, J Chemother 12 (2000), 406-411.
45. B.A. Claesson and M. Leinonen, Moraxella catarrhalis - an uncommon cause of community-acquired pneumonia in Swedish children, Scand J Infect Dis 26 (1994), 399-402.
46. K.L. Klingman, A. Pye, T.F. Murphy and S.L. Hill, Dynamics of respiratory tract colonization by Branhamella catarrhalis in bronchiectasis, Am J Respir Crit Care Med 152 (1995), 1072-1078.
47. C. Hol, C. Schalen and C.M. Verduin et al., Moraxella catarrhalis in acute laryngitis: Infection or colonization? J Infect Dis 174 (1996), 636-638.
48. S.M. Finegold, M.J. Flynn, F.V. Rose et al., Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults, Clin Infect Dis 35 (2002), 428-433.
49. I. Brook, Bacteriology of acute and chronic frontal sinusitis, Arch Otolaryngol Head Neck Surg 128 (2002), 583-585.
50. A. Ahmed, A. Broides, N. Givon-Lavi, N. Peled, R. Dagan and D. Greenberg, Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children, Pediatr Infect Dis J 27 (2008), 459-461.
51. K. Leskinen and J. Jero, Acute mastoiditis caused by Moraxella catarrhalis, Int J Pediatr Otorhinolaryngol 67 (2003), 31-33.
52. J. Stefanou, A.V. Agelopoulou, N.V. Sipsas, N. Smilakou and A. Avlami, Moraxella catarrhalis endocarditis: Case report and review of the literature, Scand J Infect Dis 32 (2000), 217-218.
53. A.T. Rotta, B.I. Asmar, N. Ballal and A. Canady, Moraxella catarrhalis ventriculitis in a child with hydrocephalus and an external ventricular drain, Pediatr Infect Dis J 14 (1995), 397-398.
54. J.A. Romberger, E.R. Wald and P.F. Wright, Branhamella catarrhalis conjunctivitis, South Med J 80 (1987), 926-928.
55. D.G. Heidemann, E. Alfonso, R.K. Forster et al., Branhamella catarrhalis keratitis, Am J Ophthalmol 103 (1987), 576-581.
56. D.T. McLeod, F. Ahmad and M.A. Calder, Branhamella catarrhalis (beta lactamase positive) ophthalmia neonatorum, Lancet 2 (1984), 647.
57. A. Leonardou, S. Giali, D. Daoussis, V. Siambi, H. Gogos and S.N. Liossis, Moraxella catarrhalis-induced septic arthritis of a prosthetic knee joint in a patient with rheumatoid arthritis treated with anakinra: Comment on the article by Schiff et al., Arthritis Rheum 52 (2005), 1337.
58. A. Daoud, F. Abuekteish and H. Masaadeh, Neonatal meningitis due to Moraxella catarrhalis and reviewof the literature, Ann Trop Paediatr 16 (1996), 199-201.
59. A.A. Kostiala and T. Honkanen, Branhamella catarrhalis as a cause of acute purulent pericarditis, J Infect 19 (1989), 291-292.
60. F. Verjano Sanchez, C. Calvo Rey and V. Nebreda Perez, Moraxella catarrhalis as a cause of osteomyelitis in the infant, An Esp Pediatr 56 (2002), 190-191 (in Spanish).
61. A. Abdolrasouli, A. Amin, M. Baharsefat, A. Roushan and Y. Hemmati, Moraxella catarrhalis associated with acute urethritis imitating gonorrhoea acquired by oral-genital contact, Int J STD AIDS 18 (2007), 579-580.
62. V. Spaniol, N. Heiniger, R. Troller and C. Aebi, Outer membrane protein UspA1 and lipooligosaccharide are involved in invasion of human epithelial cells by Moraxella catarrhalis, Microbes Infect 10 (2008), 3-11.
63. P.D. N'Guessan, M. Vigelahn, S. Bachmann et al., The UspA1 protein of Moraxella catarrhalis induces CEACAM-1-dependent apoptosis in alveolar epithelial cells, J Infect Dis 195 (2007), 1651-1660.
64. A.S. Attia, S. Ram, P.A. Rice and E.J. Hansen, Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade, Infect Immun 74 (2006), 1597-1611.
65. C.M. Verduin, M. Jansze, C. Hol, T.E. Mollnes, J. Verhoef and H. van Dijk, Differences in complement activation between complement-resistant and complementsensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation, Infect Immun 62 (1994), 589-595.
66. T. Nordstrom, A.M. Blom, A. Forsgren and K. Riesbeck, The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2, J Immunol 173 (2004), 4598-4606.
67. E.R. Lafontaine, L.D. Cope, C. Aebi, J.L. Latimer, G.H. McCracken, Jr. and E.J. Hansen, The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro, J Bacteriol 182 (2000), 1364-1373.
68. M.M. Holm, S.L. Vanlerberg, D.D. Sledjeski and E.R. Lafontaine, The Hag protein of Moraxella catarrhalis strain 035E is associated with adherence to human lung and middle ear cells, Infect Immun 71 (2003), 4977-4984.
69. A. Forsgren, M. Brant, M. Karamehmedovic and K. Riesbeck, The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin, Infect Immun 71 (2003), 3302-3309.
70. D. Peng, B.P. Choudhury, R.S. Petralia, R.W. Carlson and X.X. Gu, Roles of 3-deoxy-d-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence, Infect Immun 73 (2005), 4222-4230.
71. C. Aebi, B. Stone, M. Beucher et al., Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin, Infect Immun 64 (1996), 2024-2030.
72. R.A. Bonnah, H.Wong, S.M. Loosmore and A.B. Schryvers, Characterization of Moraxella (Branhamella) catarrhalis LbpB, LbpA, and lactoferrin receptor Orf3 isogenic mutants, Infect Immun 67 (1999), 1517-1520.
73. K.E. Mathers, D. Goldblatt, C. Aebi, R. Yu, A.B. Schryvers and E.J. Hansen, Characterisation of an outer membrane protein of Moraxella catarrhalis, FEMS Immunol Med Microbiol 19 (1997), 231-236.
74. M.M. Holm, S.L. Vanlerberg, I.M. Foley, D.D. Sledjeski and E.R. Lafontaine, The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells, Infect Immun 72 (2004), 1906-1913.
75. C. Akimana and E.R. Lafontaine, The Moraxella catarrhalis outer membrane protein CD contains two distinct domains specifying adherence to human lung cells, FEMS Microbiol Lett 271 (2007), 12-19.
76. N.R. Luke, A.J. Howlett, J. Shao and A.A. Campagnari, Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation, Infect Immun 72 (2004), 6262-6270.
77. N.R. Luke, J.A. Jurcisek, L.O. Bakaletz and A.A. Campagnari, Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation, Infect Immun 75 (2007), 5559-5564.
78. S.L. Lipski, C. Akimana, J.M. Timpe, R.M. Wooten and E.R. Lafontaine, The Moraxella catarrhalis autotransporter Mcap is a conserved surface protein that mediates adherence to human epithelial cells through its n-terminal passenger domain, Infect Immun 75 (2007), 314-324.
79. J.M. Timpe, M.M. Holm, S.L. Vanlerberg, V. Basrur and E.R. Lafontaine, Identification of a Moraxella catarrhalis outer membrane protein exhibiting both adhesin and lipolytic activities, Infect Immun 71 (2003), 4341-4350.
80. E.A. Ruckdeschel, C. Kirkham, A.J. Lesse, Z. Hu and T.F. Murphy, Mining the Moraxella catarrhalis genome: Identification of potential vaccine antigens expressed during human infection, Infect Immun 76 (2008), 1599-1607.
81. T.C. Hoopman, W. Wang, C.A. Brautigam, J.L. Sedillo, T.J. Reilly and E.J. Hansen, Moraxella catarrhalis synthesizes an autotransporter that is an acid phosphatase, J Bacteriol 190 (2008), 1459-1472.
82. A.S. Attia, J.L. Sedillo, W. Wang et al., Moraxella catarrhalis expresses an unusual Hfq protein, Infect Immun 76 (2008), 2520-2530.
83. T.T. Tan, J.J. Christensen, M.H. Dziegiel, A. Forsgren and K. Riesbeck, Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2, Infect Immun 74 (2006), 6377-6386.
84. K. Mathers, M. Leinonen and D. Goldblatt, Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media, Pediatr Infect Dis J 18 (1999), 982-988.
85. T. Ejlertsen, E. Thisted, P.A. Ostergaard and J. Renneberg, Maternal antibodies and acquired serological response to Moraxella catarrhalis in children determined by an enzyme-linked immunosorbent assay, Clin Diagn Lab Immunol 1 (1994), 464-468.
86. H. Faden, J. Hong and T. Murphy, Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media, Infect Immun 60 (1992), 3824-3829.
87. R. Takada, Y. Harabuchi, T. Himi and A. Kataura, Antibodies specific to outer membrane antigens of Moraxella catarrhalis in sera and middle ear effusions from children with otitis media with effusion, Int J Pediatr Otorhinolaryngol 46 (1998), 185-195.
88. L.E. Stenfors and S. Raisanen, Secretory IgA-, IgG- and C3B-coated bacteria in the nasopharynx of otitis-prone and non-otitis-prone children, Acta Otolaryngol 113 (1993), 191-195.
89. T.F. Murphy, A.L. Brauer, C. Aebi and S. Sethi, Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease, Infect Immun 73 (2005), 3471-3478.
90. D. Chen, V. Barniak, K.R. VanDerMeid and J.C. McMichael, The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children, Infect Immun 67 (1999), 1310-1316.
91. J.M. Braun, J. Beuth, C.C. Blackwell et al., Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens, Vaccine 22 (2004), 898-908.
92. T.T. Tan, M. Morgelin, A. Forsgren and K. Riesbeck, Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles, J Infect Dis 195 (2007), 1661-1670.
93. J. Jendholm, M. Samuelsson, L.O. Cardell, A. Forsgren and K. Riesbeck, Moraxella catarrhalis-dependent tonsillar B cell activation does not lead to apoptosis but to vigorous proliferation resulting in nonspecific IgM production, J Leukoc Biol 83 (2008), 1370-1378.
94. H.Y. Lee, A. Andalibi, P. Webster et al., Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae, BMC Infect Dis 4 (2004), 12.
95. C.K. Zetterstrom, T. Bergman, B. Rynnel-Dagoo et al., High mobility group box chromosomal protein 1 (HMGB1) is an antibacterial factor produced by the human adenoid, Pediatr Res 52 (2002), 148-154.
96. A.D. Gorter, P.S. Hiemstra, S. de Bentzmann, S. van Wetering, J. Dankert and L. van Alphen, Stimulation of bacterial adherence by neutrophil defensins varies among bacterial species but not among host cell types, FEMS Immunol Med Microbiol 28 (2000), 105-111.
97. H. Xie and X.X. Gu, Moraxella catarrhalis lipooligosaccharide selectively upregulates ICAM-1 expression on human monocytes and stimulates adjacent naive monocytes to produce TNF-alpha through cellular cross-talk, Cell Microbiol 10 (2008), 1453-1467.
98. S. Rosseau, K. Wiechmann, S. Moderer et al., Moraxella catarrhalis infected alveolar epithelium induced monocyte recruitment and oxidative burst, Am J Respir Cell Mol Biol 32 (2005), 157-166.
99. A.L. Humlicek, L. Pang and D.C. Look, Modulation of airway inflammation and bacterial clearance by epithelial cell ICAM-1, Am J Physiol Lung Cell Mol Physiol 287 (2004), L598-L607.
100. H. Slevogt, L. Maqami, K. Vardarowa et al., Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms, Eur Respir J 31 (2008), 725-735.
101. H. Slevogt, J. Seybold, K.N. Tiwari et al., Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2- and partly NOD1-dependent inflammatory immune response, Cell Microbiol 9 (2007), 694-707.
102. Inohara, Chamaillard, C. McDonald and G. Nunez, NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease, Annu Rev Biochem 74 (2005), 355-383.
103. E. Juni, G.A. Heym and M. Avery, Defined medium for Moraxella (Branhamella) catarrhalis, Appl Environ Microbiol 52 (1986), 546-551.
104. M. Vaneechoutte, G. Verschraegen, G. Claeys and A.M. van den Abeele, Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp, J Clin Microbiol 26 (1988), 2544-2548.
105. E. Speeleveld, J.M. Fossepre, B. Gordts and H.W. Van Landuyt, Comparison of three rapid methods, tributyrine, 4-methylumbelliferyl butyrate, and indoxyl acetate, for rapid identification of Moraxella catarrhalis, J Clin Microbiol 32 (1994), 1362-1363.
106. O. Greiner, P.J. Day, M. Altwegg and D. Nadal, Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR, J Clin Microbiol 41 (2003), 1386-1390.
107. M. Kais, C. Spindler, M. Kalin, A. Ortqvist and C.G. Giske, Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR, Diagn Microbiol Infect Dis 55 (2006), 169-178.
108. U. Gok, Y. Bulut, E. Keles, S. Yalcin and M.Z. Doymaz, Bacteriological and PCR analysis of clinical material aspirated from otitis media with effusions, Int J Pediatr Otorhinolaryngol 60 (2001), 49-54.
109. J.J. Aul, K.W. Anderson, R.M. Wadowsky et al., Comparative evaluation of culture and PCR for the detection and determination of persistence of bacterial strains and DNAs in the chinchilla laniger model of otitis media, Ann Otol Rhinol Laryngol 107 (1998), 508-513.
110. J.C. Post, J.J. Aul, G.J. White et al., PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis media, Am J Otolaryngol 17 (1996), 106-111.
111. B. Pettersson, A. Kodjo, M. Ronaghi, M. Uhlen and T. Tonjum, Phylogeny of the family Moraxellaceae by 16s rDNA sequence analysis, with special emphasis on differentiation of Moraxella species, Int J Syst Bacteriol 48(Pt 1) (1998), 75-89.
112. S.J. Verhaegh, A. Streefland, J.K. Dewnarain, D.J. Farrell, A. van Belkum and J.P. Hays, Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001-2002, Microbiology 154 (2008), 1178-1184.
113. B.Wolf, M. Kools-Sijmons, C. Verduin et al., Genetic diversity among strains of Moraxella catarrhalis cultured from the nasopharynx of young and healthy Brazilian, Angolan and Dutch children, Eur J Clin Microbiol Infect Dis 19 (2000), 759-764.
114. E.S. Walker, R.A. Preston, J.C. Post, G.D. Ehrlich, J.H. Kalbfleisch and K.L. Klingman, Genetic diversity among strains of Moraxella catarrhalis: Analysis using multiple DNA probes and a single-locus PCR-restriction fragment length polymorphism method, J Clin Microbiol 36 (1998), 1977-1983.
115. N.M. Pingault, D. Lehmann, J. Bowman and T.V. Riley, A comparison of molecular typing methods for Moraxella catarrhalis, J Appl Microbiol 103 (2007), 2489-2495.
116. A. Schaller, R. Troller, D. Molina, S. Gallati, C. Aebi and P. Stutzmann Meier, Rapid typing of Moraxella catarrhalis subpopulations based on outer membrane proteins using mass spectrometry, Proteomics 6 (2006), 172-180.
117. M. Vaneechoutte, G. Verschraegen, G. Claeys and A.M. Van Den Abeele, Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens, J Clin Microbiol 28 (1990), 182-187.
118. A.B. Hoi-Dang, C. Brive-Le Bouguenec, M. Barthelemy and R. Labia, Novel beta-lactamase from Branhamella catarrhalis, Ann Microbiol (Paris) 129(B) (1978), 397-406.
119. S.E. Beekmann, K.P. Heilmann, S.S. Richter, J. Garcia-de-Lomas and G.V. Doern, Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group a beta-haemolytic Streptococci in 2002-2003. Results of the multinational GRASP surveillance program, Int J Antimicrob Agents 25 (2005), 148-156.
120. M. Gracia, C. Diaz, P. Coronel et al., Antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis isolates in eight central, east and baltic European countries in 2005-06: Results of the cefditoren surveillance study, J Antimicrob Chemother 61 (2008), 1180-1181.
121. H.J. Bootsma, H. van Dijk, J. Verhoef, A. Fleer and F.R. Mooi, Molecular characterization of the bro beta-lactamase of Moraxella (Branhamella) catarrhalis, Antimicrob Agents Chemother 40 (1996), 966-972.
122. R.J. Wallace, Jr., V.A. Steingrube, D.R. Nash et al., BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata, Antimicrob Agents Chemother 33 (1989), 1845-1854.
123. M.R. Jacobs, S. Bajaksouzian, A. Windau et al., Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 US surveillance study, Clin Lab Med 24 (2004), 503-530.
124. F. Walsh, F. Carnegy, J. Willcock and S. Amyes, Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae, J Antimicrob Chemother 53 (2004), 793-796.
125. D.M. Johnson, H.S. Sader, T.R. Fritsche, D.J. Biedenbach and R.N. Jones, Susceptibility trends of Haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY antimicrobial surveillance program, Diagn Microbiol Infect Dis 47 (2003), 373-376.
126. J.M. Bell, J.D. Turnidge and R.N. Jones, Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the western pacific region and South Africa: Report from the sentry antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756, Int J Antimicrob Agents 19 (2002), 125-132.
127. P. Karpanoja, S.T. Nyberg, M. Bergman et al., The connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis, Antimicrob Agents Chemother 52 (2008), 2480-2485.
128. H. Faden, J. Bernstein, L. Brodsky, J. Stanievich and P.L. Ogra, Effect of prior antibiotic treatment on middle ear disease in children, Ann Otol Rhinol Laryngol 101 (1992), 87-91.
129. P.P.G. van Benthem, Commentary on 'antibiotics for the prevention of acute and chronic suppurative otitis media in children', with response from review author, Evidence-Based Child Health: A Cochrane Review Journal 2 (2007), 763-766.
130. T.T. Tan and K. Riesbeck, Current progress of adhesins as vaccine candidates for Moraxella catarrhalis, Expert Rev Vaccines 6 (2007), 949-956.
131. K. Riesbeck, T.T. Tan and A. Forsgren, Mid and UspA1/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development, Acta Biochim Pol 53 (2006), 445-456.
132. P.S. Meier, S. Freiburghaus, A. Martin, N. Heiniger, R. Troller and C. Aebi, Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children, Pediatr Infect Dis J 22 (2003) 256-262.
133. R.H. Yu, R.A. Bonnah, S. Ainsworth and A.B. Schryvers, Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis, Infect Immun 67 (1999), 3793-3799.
134. J. Sarwar, A.A. Campagnari, C. Kirkham and T.F. Murphy, Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis, Infect Immun 60 (1992), 804-809.
135. J.P. Hays, S. van Selm, T. Hoogenboezem et al., Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms, J Bacteriol 187 (2005), 7977-7984.
136. X.X. Gu, J. Chen, S.J. Barenkamp et al., Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis, Infect Immun 66 (1998 , 1891-1897.
137. S. Yu and X.X. Gu, Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis, Infect Immun 73 (2005), 2790-2796.
138. S. Yu and X.X. Gu, Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis, Infect Immun 75 (2007), 2974-2980.
139. P.S. Meier, R. Troller, N. Heiniger, I.N. Grivea, G.A. Syrogiannopoulos and C. Aebi, Moraxella catarrhalis strains with reduced expression of the UspA outer membrane proteins belong to a distinct subpopulation, Vaccine 23 (2005), 2000-2008.
140. R. Prymula, P. Peeters, V. Chrobok et al., Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: A randomised double-blind efficacy study, Lancet 367 (2006), 740-748.
141. K.W. Mason, D. Zhu, C.A. Scheuer, J.C. McMichael, G.W. Zlotnick and B.A. Green, Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529, Vaccine 22 (2004), 3449-3456.
142. F.Mawas, M.M. Ho, R. Huskisson, M. Saydam and M.J. Corbel, Physico-chemical characterisation and immunogenicity of a multi-valent candidate vaccine against non-typeable Haemophilus influenzae and Moraxella catarrhalis, Vaccine 25 (2007), 4801-4808.